Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation—‘beyond the TAP study’
Open Access
- 13 February 2004
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 18 (8), 809-813
- https://doi.org/10.1038/sj.eye.6701329
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Verteporfin photodynamic therapy in the UK: implications of the NICE appraisalEye, 2003
- Photodynamic therapy in the treatment of subfoveal choroidal neovascularisationEye, 2001
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfinOphthalmology, 2001
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999
- The Prevalence of Age-related Maculopathy in the Rotterdam StudyOphthalmology, 1995
- Prevalence of Age-related MaculopathyOphthalmology, 1992
- Early Treatment Diabetic Retinopathy Study Design and Baseline Patient CharacteristicsOphthalmology, 1991
- Age-related macular degenerationSurvey of Ophthalmology, 1988
- Argon Laser Photocoagulation for Senile Macular DegenerationArchives of Ophthalmology (1950), 1982